Loading organizations...
Loading organizations...
Clinical-stage biopharmaceutical company transforming gout treatment.
Crystalys Therapeutics has raised $205.0M across 1 funding round.
Crystalys Therapeutics has raised $205.0M in total across 1 funding round.
Crystalys Therapeutics has raised $205.0M in total across 1 funding round.
Crystalys Therapeutics's investors include Ashwin Ram, Novo Holdings, SR One, abrdn, Alexandria Venture Investments, AN Ventures, KB Investment, Lightstone Ventures, Longwood Fund, Perceptive Xontogeny Venture Fund, Pontifax, Prebys Ventures Fund.
Crystalys Therapeutics has raised $205.0M across 1 funding round. Most recently, it raised $205.0M Series A in September 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 30, 2025 | $205.0M Series A | Ashwin Ram, Novo Holdings, SR One | abrdn, Alexandria Venture Investments, AN Ventures, KB Investment, Lightstone Ventures, Longwood Fund, Perceptive Xontogeny Venture Fund, Pontifax, Prebys Ventures Fund, Wedbush Healthcare Partners |